PharmaCyte Biotech Inc (PMCB)

[Rameses]

Yes, lots of shorting. Every single share Iroquois had at $4+ in the two public offerings were sold off in the run up to $9.98 (even higher in AH trading) on 229,464,864 volume on August 18, 2021. That run triggered the warrants which they received, and then Iroquois and others proceeded to short it back down to $2 and less range. On the way up they made money, and on the way down they made money, and they collected shares from their warrants in the process. They then started using some of the money they made from selling and shorting PMCB to build a position and add to the shares they got from the warrants which today equals 6.7% of the O/S from $1.79 - $2.50. It's not that difficult to do.

There seems to be a disconnect that a hedge fund can't sell off its initial investment position if they have still have 6.7%. They can sell it off, make millions, and then buy it back using some of that money. The O/S is only 22 million-ish shares so it's not that difficult. That is about 1.4 million shares so it only costs a fraction of the millions they made selling on the way up to $9.98 and then shorting it back to $2 and below especially given they already had a starter position with the warrants they triggered on August 18, 2021.